@dansfera: Pharmaceutical fast-track unlocked! 🤯 See how Equestive Therapeutics' LibraVent, a simple reformulation of the anti-seizure drug diazepam (changing from gel to buccal film), got to skip the usual FDA advisory panel. When the safety data is already locked in from decades of use, the path to approval gets *a lot* shorter. A fascinating peek behind the regulatory curtain on how established drugs can get new delivery methods approved quickly! #FDARules #DrugReformulation #PharmaNews #Biotech #AQST